TABLE 3.
Differences in African lung nodule strains from the EEHV2 and EEHV6 prototypes
| PCR locus | No. of nucleotide differences/total no. of nucleotides (%) across selected locia |
||||||
|---|---|---|---|---|---|---|---|
| EEHV2 |
EEHV6 |
||||||
| AfLng54 vs NAP12 | NAP42 vs NAP12 | SAM7 vs NAP12 | EP26 vs NAP12 | NAP42 vs NAP35 | SAM6 vs NAP35 | EP26 vs NAP35 | |
| U39(gB) | 1/2,313 | 16/2,354 | |||||
| U38(POL) | 11/2,313 | 12/419 | 1/487 | 8/2,364 | 6/467 | ||
| U33(Cys-R) | 20/851 | 10/916 | |||||
| U28-27.5(RRA-B) | 14/2,043 | 4/880 | |||||
| U27-U46-47(PPF-gN-gO) | 16/2,558 | 31/2,516 | |||||
| U48(gH) | 1/501 | 74/539 | |||||
| U48.5(TK)-U49 | 3/1,195 | 53/922 | 30/1,029 | ||||
| U49-50(PAC2) | 11/1,702 | 11/1,105 | |||||
| U51(vGPCR1) | 171/1,042 | 3/832 | |||||
| U57(MCP) | 15/2,767 | 5/2,244 | |||||
| U60-62(TERex3) | 6/816 | 10/874 | 2/347 | ||||
| U66(TERex1) | 10/914 | 2/325 | |||||
| U71-72(MyrTeg-gM) | 18/2,674 | 3/667 | |||||
| U73(OBP) | 0/568 | 1/181 | 1/832 | 0/470 | 14/558 | ||
| U76-77(POR-HELn) | 24/1,864 | 12/1,867 | 9/943 | ||||
| U77-U78.5(HELc-ORF-Mn) | 4/1,082 | 2/1,300 | |||||
| U77.5-U80.5(ORF-Mc-vCXCL1) | 4/970 | 53/900 | |||||
| U81-U82(UDG) | 9/954 | 22/957 | |||||
| U82(gL) | 9/1,001 | 30/819 | |||||
| U85.5(ORF-Kex3) | 11/1,431 | 16/1,371 | |||||
| U86.5(ORF-L) | 6/748 | 22/2,253 | |||||
| Total | 363/29,523 (1.25) | 12/214 | 1/581 | 55/1,990 | 367/27002 (1.45) | 17/2,227 | 14/558 |
a
Data in boldface type represent ORF segments that diverge by >3% between the two strains.